Dispatches from a Pandemic: Johnson & Johnson saga reveals critical strengths in the U.S. COVID-19 mass-vaccination strategy — and its weaknesses
‘Part of Operation Warp Speed was not knowing which ones would cross the finish line,’ said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security.

from MarketWatch.com - Top Stories https://ift.tt/3tn8ggc
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3tn8ggc
via IFTTT
Kommentare
Kommentar veröffentlichen